144 related articles for article (PubMed ID: 6498794)
1. Effect of 2-beta-D-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cells.
Karle JM; Monks A; Wolfe RM; Cysyk RL
Cancer Lett; 1984 Aug; 24(1):11-8. PubMed ID: 6498794
[TBL] [Abstract][Full Text] [Related]
2. Uptake of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) and analogues by the facilitated transport mechanism of erythrocytes.
Monks A; Marquez VE; Mao DT; Cysyk RL
Cancer Lett; 1985 Aug; 28(1):1-8. PubMed ID: 4027951
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
Berger NA; Berger SJ; Catino DM; Petzold SJ; Robins RK
J Clin Invest; 1985 Feb; 75(2):702-9. PubMed ID: 3919063
[TBL] [Abstract][Full Text] [Related]
5. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
Cadman E; Benz C
Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
Srivastava PC; Revankar GR; Robins RK
J Med Chem; 1984 Mar; 27(3):266-9. PubMed ID: 6699872
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
8. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
Jayaram HN; Dion RL; Glazer RI; Johns DG; Robins RK; Srivastava PC; Cooney DA
Biochem Pharmacol; 1982 Jul; 31(14):2371-80. PubMed ID: 6127085
[No Abstract] [Full Text] [Related]
9. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.
Moyer JD; Karle JM; Malinowski N; Marquez VE; Salam MA; Malspeis L; Cysyk RL
Mol Pharmacol; 1985 Nov; 28(5):454-60. PubMed ID: 2997596
[TBL] [Abstract][Full Text] [Related]
11. Tiazofurin and selenazofurin induce depression of cGMP and phosphatidylinositol pathway in L1210 leukemia cells.
Parandoosh Z; Robins RK; Belei M; Rubalcava B
Biochem Biophys Res Commun; 1989 Oct; 164(2):869-74. PubMed ID: 2554903
[TBL] [Abstract][Full Text] [Related]
12. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
Karle JM; Anderson LW; Cysyk RL
J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
Jayaram HN; Cooney DA; Glazer RI; Dion RL; Johns DG
Biochem Pharmacol; 1982 Aug; 31(15):2557-60. PubMed ID: 7126269
[No Abstract] [Full Text] [Related]
15. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides.
Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK
Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
Jayaram HN; Smith AL; Glazer RI; Johns DG; Cooney DA
Biochem Pharmacol; 1982 Dec; 31(23):3839-45. PubMed ID: 6130768
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
Moyer JD; Smith PA; Levy EJ; Handschumacher RE
Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
20. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin.
Weber G; Lui MS; Jayaram HN; Pillwein K; Natsumeda Y; Faderan MA; Reardon MA
Adv Enzyme Regul; 1985; 23():81-99. PubMed ID: 3907307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]